Latest News and Press Releases

WESTLAKE VILLAGE, Calif., Sept. 07, 2021 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of inhaled therapeutic products for...

Conference Call to Begin Today at 5:00 PM ET 2Q 2021 Total Revenues of $23.3 million; +54% vs. 2Q 20202Q 2021 Afrezza Net Revenue of $10.0 million; +43% vs. 2Q 2020$201.4 million of Cash, Cash...

WESTLAKE VILLAGE, Calif., Aug. 04, 2021 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD) will release its 2021 second quarter financial results and its management will host a conference call...

WESTLAKE VILLAGE, Calif., Aug. 03, 2021 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of inhaled therapeutic products for...

Tyvaso DPI includes the second compound formulated with MannKind’s Technosphere® technology to be reviewed by the FDAFDA review expected to be complete in October 2021Hiring expansion underway at...

MannKind will conduct formulation and preclinical studies of a new chemical entity owned by ThironaIn addition, MannKind purchased a convertible note issued by ThironaWESTLAKE VILLAGE, Calif. and...

WESTLAKE VILLAGE, Calif., June 08, 2021 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of inhaled therapeutic products for...

Daly to drive bold “Tired of Pricks?” design for Ed Carpenter Racingat GMR Grand Prix on May 15 at Indianapolis Motor Speedway Indiana native to share personal journey and raise awarenessabout...

Conference Call to Begin Today at 5:00 PM ET 1Q 2021 Total Revenues of $17.4 million; +7% vs. 1Q 2020Received $230.0 million gross proceeds from 2.5% senior convertible notes$278.3 million of Cash,...

WESTLAKE VILLAGE, Calif., May 11, 2021 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of inhaled therapeutic products for...